{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > JAK/STAT > AbrocitinibCAS：1622902-68-4
Molecular Formula：C14H21N5O2S
Molecular Weight：323.41
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 1622902-68-4 |
| Name | Abrocitinib |
| Molecular Formula | C14H21N5O2S |
| Molecular Weight | 323.41 |
| Solubility | Soluble in DMSO ≥5mg/mL(Need ultrasonic) |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| SMILES | CN([C@H]1C[C@@H](NS(CCC)(=O)=O)C1)C2=C3C(NC=C3)=NC=N2 |
| Target Point | JAK，TYK2 |
| Passage | JAK/STAT Signaling |
| Background | Abrocitinib is a novel, potent JAK1 inhibitor |
| Biological Activity | Abrocitinib (PF-04965842) is a potent， orally active and selective JAK1 inhibitor， with IC50s of 29 and 803 nM for JAK1 and JAK2， respectively. Abrocitinib (PF-04965842) exhibits less active effect on TYK2 (IC50， 1.253 μM)， and inhibits phosphorylation of STAT1， STAT3 and STAT5 after stimulation. Effective in autoimmune disease[1]. |
| Data Literature Source | [1]. Vazquez ML，et al. Identification of N-{cis-3-[Methyl(7H-pyrrolo[2，3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases. J Med Chem. 2018 Feb 8;61(3):1130-115 |
| Unit | Bottle |
| Specification | 2mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
